Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cogenzia in Diabetic Foot Infection (COACT-1)
NCT02427802Phase 3Completed
- Sponsor
- Innocoll
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cogenzia in diabetic foot infection (DFI), sponsored by Innocoll. Started May 2015; status: completed.
02
Drugs
Cogenzia
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT02427802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427802.